Molecular basis of the differential sensitivity of nematode and mammalian muscle to the anthelmintic agent levamisole.
Levamisole is an anthelmintic agent that exerts its therapeutic effect by acting as a full agonist of the nicotinic receptor (AChR) of nematode muscle. Its action at the mammalian muscle AChR has not been elucidated to date despite its wide use as an anthelmintic in humans and cattle. By single channel and macroscopic current recordings, we investigated the interaction of levamisole with the mammalian muscle AChR. Levamisole activates mammalian AChRs. However, single channel openings are briefer than those activated by acetylcholine (ACh) and do not appear in clusters at high concentrations. The peak current induced by levamisole is about 3% that activated by ACh. Thus, the anthelmintic acts as a weak agonist of the mammalian AChR. Levamisole also produces open channel blockade of the AChR. The apparent affinity for block (190 microm at -70 mV) is similar to that of the nematode AChR, suggesting that differences in channel activation kinetics govern the different sensitivity of nematode and mammalian muscle to anthelmintics. To identify the structural basis of this different sensitivity, we performed mutagenesis targeting residues in the alpha subunit that differ between vertebrates and nematodes. The replacement of the conserved alphaGly-153 with the homologous glutamic acid of nematode AChR significantly increases the efficacy of levamisole to activate channels. Channel activity takes place in clusters having two different kinetic modes. The kinetics of the high open probability mode are almost identical when the agonist is ACh or levamisole. It is concluded that alphaGly-153 is involved in the low efficacy of levamisole to activate mammalian muscle AChRs.
Rayes
Diego
D
Instituto de Investigaciones Bioquímicas de Bahía Blanca, UNS-CONICET, Camino La Carrindanga, Km 7B-8000FWB Bahía Blanca, Argentina.
De Rosa
María José
MJ
Bartos
Mariana
M
Bouzat
Cecilia
C
D000595:Amino Acid Sequence; D000818:Animals; D000969:Antinematodal Agents / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D018698:Glutamic Acid / Q000737:chemistry; D005998:Glycine / Q000737:chemistry; D006801:Humans; D007700:Kinetics; D007978:Levamisole / Q000494:pharmacology*; D008564:Membrane Potentials; D051379:Mice; D008956:Models, Chemical; D008969:Molecular Sequence Data; D009132:Muscles / Q000187:drug effects; D016296:Mutagenesis; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D009348:Nematoda; D018408:Patch-Clamp Techniques; D011950:Receptors, Cholinergic / Q000378:metabolism; D012680:Sensitivity and Specificity; D013997:Time Factors; D014162:Transfection
D000969:Antinematodal Agents; D011950:Receptors, Cholinergic; D007978:Levamisole; D018698:Glutamic Acid; D005998:Glycine